Pre-earnings options volume in DexCom (DXCM) is 2.6x normal with puts leading calls 9:5. Implied volatility suggests the market is anticipating a move near 8.6%, or $6.12, after results are released. Median move over the past eight quarters is 5.6%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM:
- Is DXCM a Buy, Before Earnings?
- ISRG, LLY, or DXCM: Which “Strong Buy” Healthcare Stock Has the Highest Upside Potential?
- DexCom price target lowered to $100 from $115 at RBC Capital
- DexCom price target lowered to $107 from $120 at BTIG
- Dexcom’s G7 Sensor Approval Boosts Buy Rating Amid Strategic Advancements